The global Fecal Calprotectin Testing Market was valued at USD 4.51 billion in 2023 and is projected to reach USD 12.23 billion by 2032, expanding at a compound annual growth rate (CAGR) of 11.61% during the forecast period of 2024–2032, according to a new report by SNS Insider. The rising global burden of inflammatory bowel disease (IBD), Crohn’s disease, and other...